|
127 Companies |
|
123 Products |
|
123 Products |
|
59 Mechanisms of Action |
|
6 Trials |
|
3245 News |
|
| «12...4647484950515253545556...6566» |
- Trial completion: Changes in Microbiota and Iron Status After Iron Fortification of Complementary Foods (clinicaltrials.gov) - Jun 5, 2013
P=N/A, N=160, Completed, Sponsor: Swiss Federal Institute of Technology
Active, not recruiting --> Completed
- | Trial suspension: Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects 2 Years of Age and Older (clinicaltrials.gov) - Jun 4, 2013
P=N/A, N=3000, Suspended, Sponsor: Novartis Vaccines
Active, not recruiting --> Completed Not yet recruiting --> Suspended
- Enrollment change: TBNEATXpert;TBNEATXpertRCT: Trial of Point-of-treatment Xpert MTB/RIF Assay (clinicaltrials.gov) - Jun 3, 2013
P=N/A, N=1472, Completed, Sponsor: University of Cape Town
Not yet recruiting --> Suspended N=1200 --> 1472
- Trial completion: TBNEATXpert;TBNEATXpertRCT: Trial of Point-of-treatment Xpert MTB/RIF Assay (clinicaltrials.gov) - Jun 3, 2013
P=N/A, N=1472, Completed, Sponsor: University of Cape Town
N=1200 --> 1472 Recruiting --> Completed
- |||| Solithera (solithromycin) / Melinta Therap, Fujifilm Holdings
Trial completion: Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea (clinicaltrials.gov) - Jun 3, 2013
P2, N=60, Completed, Sponsor: Cempra Pharmaceuticals
Recruiting --> Completed Recruiting --> Completed
- || New P3 trial: Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial (clinicaltrials.gov) - Jun 2, 2013
P3, N=1400, Recruiting, Sponsor: Makerere University
- GC1109 / Green Cross
New P1 trial: Efficacy and Safety of Anthrax Vaccine, GC1109 (clinicaltrials.gov) - Jun 2, 2013
P1, N=20, Completed, Sponsor: Seoul National University Hospital
- Enrollment change: Levo?oxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection (clinicaltrials.gov) - May 31, 2013
P4, N=200, Completed, Sponsor: Shanghai Jiao Tong University School of Medicine
Recruiting --> Completed N=100 --> 200
- Trial completion: Levo?oxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection (clinicaltrials.gov) - May 31, 2013
P4, N=200, Completed, Sponsor: Shanghai Jiao Tong University School of Medicine
N=100 --> 200 Recruiting --> Completed
- | GSK692342 / GSK, Bill & Melinda Gates Foundation
Trial completion, IO biomarker: Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342 (clinicaltrials.gov) - May 29, 2013
P2, N=20, Completed, Sponsor: GlaxoSmithKline
Recruiting --> Completed Active, not recruiting --> Completed
- |||||| Nimenrix (MenACWY-TT) / Pfizer
Enrollment open: Immunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary Vaccination (clinicaltrials.gov) - May 29, 2013
P3, N=260, Recruiting, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Trial completion: Optimization of Tuberculosis Intradermal Skin Test (clinicaltrials.gov) - May 29, 2013
P=N/A, N=59, Completed, Sponsor: Hospices Civils de Lyon
Not yet recruiting --> Recruiting Recruiting --> Completed
- Mycobutin (rifabutin) / Pfizer, Lupin, Isentress (raltegravir) / Merck (MSD)
Enrollment open: Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV (clinicaltrials.gov) - May 28, 2013
P2, N=471, Recruiting, Sponsor: AIDS Clinical Trials Group
Recruiting --> Completed Not yet recruiting --> Recruiting
- Altabax (retapamulin) / GSK, Almirall
Trial withdrawal: Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization (clinicaltrials.gov) - May 27, 2013
P4, N=0, Withdrawn, Sponsor: Ochsner Health System
Not yet recruiting --> Recruiting Not yet recruiting --> Withdrawn
- Altabax (retapamulin) / GSK, Almirall
Enrollment change: Efficacy Study of Altabax to Clear Methicillin-resistant Staphylococcus Aureus (MRSA) Nasal Colonization (clinicaltrials.gov) - May 27, 2013
P4, N=0, Withdrawn, Sponsor: Ochsner Health System
Not yet recruiting --> Withdrawn N=300 --> 0
- clarithromycin / Generic mfg.
Trial initiation date: Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients (clinicaltrials.gov) - May 26, 2013
P4, N=7, Completed, Sponsor: University Medical Centre Groningen
N=300 --> 0 Initiation date: Sep 2011 --> Dec 2011
- clarithromycin / Generic mfg.
Trial completion: Drug Interaction Study Between Linezolid and Clarithromycin in Tuberculosis Patients (clinicaltrials.gov) - May 26, 2013
P4, N=7, Completed, Sponsor: University Medical Centre Groningen
Initiation date: Sep 2011 --> Dec 2011 Recruiting --> Completed
- ||||||| RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine) / Merck (MSD), Vaxelis (diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed, inactivated poliovirus, haemophilus b conjugate and hepatitis B vaccine) / Merck (MSD), Sanofi
Trial completion: Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13 (clinicaltrials.gov) - May 23, 2013
P3, N=1473, Completed, Sponsor: Merck Sharp & Dohme Corp.
Recruiting --> Completed Active, not recruiting --> Completed
- ||||| AERAS-404 / Sanofi
New P1/2 trial: Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants (clinicaltrials.gov) - May 22, 2013
P1/2, N=229, Recruiting, Sponsor: Aeras
- Trial completion: Single Dose, Weight-Based, Dose-Escalation Study With Intravenous ETI-204 in Adult Volunteers (clinicaltrials.gov) - May 21, 2013
P1, N=108, Completed, Sponsor: Elusys Therapeutics
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment closed: Efficacy Against TB Disease, Safety, and Immunogenicity of MVA85A/AERAS-485 in HIV-Infected Adults (C-030-485) (clinicaltrials.gov) - May 20, 2013
P2, N=650, Active, not recruiting, Sponsor: Aeras
Recruiting --> Completed Recruiting --> Active, not recruiting
- Trial completion: Pilot Introduction of Oral Cholera Vaccine in Orissa, India (clinicaltrials.gov) - May 20, 2013
P=N/A, N=31552, Completed, Sponsor: International Vaccine Institute
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment change: Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in Kenya (clinicaltrials.gov) - May 16, 2013
P4, N=1259, Completed, Sponsor: KNCV Tuberculosis Foundation
Active, not recruiting --> Completed N=1800 --> 1259
- Trial completion: Feasibility and Effectiveness of Community Based Isoniazid Preventive Therapy in Kenya (clinicaltrials.gov) - May 16, 2013
P4, N=1259, Completed, Sponsor: KNCV Tuberculosis Foundation
N=1800 --> 1259 Active, not recruiting --> Completed
- Trial initiation date, IO biomarker: Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers (clinicaltrials.gov) - May 15, 2013
P1, N=48, Active, not recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Initiation date: Jul 2011 --> Feb 2012
- | New P1 trial: Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis (clinicaltrials.gov) - May 15, 2013
P1, N=12, Recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
- ||| vancomycin / Generic mfg., linezolid oral / Generic mfg.
Clinical data, Trial completion: Clinical Outcomes of Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Based Pneumonia (clinicaltrials.gov) - May 14, 2013
P=N/A, N=5271, Completed, Sponsor: Pfizer
Initiation date: Jul 2011 --> Feb 2012 Active, not recruiting --> Completed
- SQ-109 / Sequella
Trial suspension: Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers (clinicaltrials.gov) - May 13, 2013
P2a, N=30, Suspended, Sponsor: Sequella, Inc.
Active, not recruiting --> Completed Recruiting --> Suspended
- sildenafil / Generic mfg.
New P1/2 trial, Nontuberculous mycobacteria: Sildenafil for PNTM Infection (clinicaltrials.gov) - May 13, 2013
P1/2, N=15, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Enrollment open: Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in Mongolia (clinicaltrials.gov) - May 13, 2013
P=N/A, N=350, Recruiting, Sponsor: Harvard School of Public Health
Recruiting --> Suspended Not yet recruiting --> Recruiting
- Trial completion: Efficacy of Antituberculous Therapy in Management of Sarcoidosis (clinicaltrials.gov) - May 12, 2013
P=N/A, N=100, Completed, Sponsor: Postgraduate Institute of Medical Education and Research
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||||||| Trial completion: Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants (clinicaltrials.gov) - May 12, 2013
P3, N=7744, Completed, Sponsor: Novartis
Recruiting --> Completed Active, not recruiting --> Completed
- Enrollment change: Metronidazole for Pulmonary Tuberculosis (South Korea) (clinicaltrials.gov) - May 9, 2013
P2, N=35, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed N=80 --> 35
- Trial completion: Metronidazole for Pulmonary Tuberculosis (South Korea) (clinicaltrials.gov) - May 9, 2013
P2, N=35, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
N=80 --> 35 Active, not recruiting --> Completed
- ||||||| PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer
Trial completion, Pneumococcal vaccines: Safety and Immunogenicity of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in HIV-Infected Subjects 6 Years of Age or Older Who Are Naive to Pneumococcal Vaccine (clinicaltrials.gov) - May 7, 2013
P3, N=303, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Clinical: SOVS-CTG: Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing (clinicaltrials.gov) - May 6, 2013
P=N/A, N=3500, Not yet recruiting, Sponsor: University of California, San Francisco
- ||||||| Trial completion: Safety and Efficacy Study to Treat Bacterial Vaginosis (clinicaltrials.gov) - May 6, 2013
P3, N=651, Completed, Sponsor: Medicis Global Service Corporation
Active, not recruiting --> Completed Active, not recruiting --> Completed
- nevirapine / Generic mfg., lopinavir/ritonavir / Generic mfg.
Trial initiation date: DATiC: Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study) (clinicaltrials.gov) - May 6, 2013
P4, N=240, Recruiting, Sponsor: University of Cape Town
Active, not recruiting --> Completed Initiation date: Jul 2012 --> Nov 2012
- nevirapine / Generic mfg., lopinavir/ritonavir / Generic mfg.
Enrollment open: DATiC: Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study) (clinicaltrials.gov) - May 6, 2013
P4, N=240, Recruiting, Sponsor: University of Cape Town
Initiation date: Jul 2012 --> Nov 2012 Not yet recruiting --> Recruiting
- Trial termination: Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis Research (clinicaltrials.gov) - May 2, 2013
P=N/A, N=480, Terminated, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting --> Recruiting Recruiting --> Terminated
- ||| doripenem / Generic mfg.
Trial initiation date: A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections (clinicaltrials.gov) - May 2, 2013
P4, N=170, Completed, Sponsor: Janssen Pharmaceutica
Recruiting --> Terminated Initiation date: Aug 2009 --> Nov 2009
- ||| doripenem / Generic mfg.
Enrollment change: A Study of the Safety and Effectiveness of Doripenem in Filipino Patients With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Complicated Urinary Tract Infections (clinicaltrials.gov) - May 2, 2013
P4, N=170, Completed, Sponsor: Janssen Pharmaceutica
Initiation date: Aug 2009 --> Nov 2009 N=86 --> 170
- Trial completion: Rapid Diagnostic Test for Detection of Group B Streptococcus in Pregnancy (clinicaltrials.gov) - May 1, 2013
P=N/A, N=358, Completed, Sponsor: The University of Texas Health Science Center, Houston
N=86 --> 170 Recruiting --> Completed
- lansoprazole / Generic mfg., clarithromycin / Generic mfg., amoxicillin / Generic mfg.
Trial completion: Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura (clinicaltrials.gov) - Apr 30, 2013
P4, N=26, Completed, Sponsor: Mahidol University
Recruiting --> Completed Recruiting --> Completed
- Enrollment change: Comparative Study of Two Tetanus Toxoid Vaccination Strategies: Cold Chain Versus Controlled Temperature Chain (clinicaltrials.gov) - Apr 30, 2013
P=N/A, N=2129, Completed, Sponsor: Epicentre
Recruiting --> Completed N=3028 --> 2129
- Enrollment change: Mentor Mothers: A Sustainable Family Intervention in South African Townships (clinicaltrials.gov) - Apr 30, 2013
P2, N=1200, Completed, Sponsor: University of California, Los Angeles
N=3028 --> 2129 N=1632 --> 1200
- Trial completion: Comparative Study of Two Tetanus Toxoid Vaccination Strategies: Cold Chain Versus Controlled Temperature Chain (clinicaltrials.gov) - Apr 30, 2013
P=N/A, N=2129, Completed, Sponsor: Epicentre
N=1632 --> 1200 Recruiting --> Completed
- Trial completion: Mentor Mothers: A Sustainable Family Intervention in South African Townships (clinicaltrials.gov) - Apr 30, 2013
P2, N=1200, Completed, Sponsor: University of California, Los Angeles
Recruiting --> Completed Recruiting --> Completed
- Enrollment closed: Protecting Pregnant Women From Infectious Diseases (clinicaltrials.gov) - Apr 24, 2013
P=N/A, N=330, Active, not recruiting, Sponsor: Emory University
Recruiting --> Completed Recruiting --> Active, not recruiting
- |||| Rifalazil (benzoxazinorifamycin) / TrioBiotics
Trial completion: Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women (clinicaltrials.gov) - Apr 24, 2013
P2, N=82, Completed, Sponsor: ActivBiotics Pharma, LLC
Recruiting --> Active, not recruiting Recruiting --> Completed